STOCK TITAN

Trupanion (TRUP) EVP Weinrauch sells 6,674 shares, exercises 8,500 options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

TRUPANION, INC. executive Steve Weinrauch, EVP North America & Vet Strategy, reported an exercise-and-sell transaction in company stock. He sold 6,674 shares of common stock in an open-market sale at a weighted average price of $22.00 per share, with individual trades ranging from $21.95 to $22.04.

On the same date, he exercised 8,500 stock options with a $15.46 exercise price, converting them into common shares and fully exhausting that option grant. Following these transactions, Weinrauch directly owns 78,062 shares of Trupanion common stock.

Positive

  • None.

Negative

  • None.
Insider WEINRAUCH STEVE
Role EVP, North Am & Vet Strategy
Sold 6,674 shs ($147K)
Type Security Shares Price Value
Exercise Stock Option (right to buy) 8,500 $0.00 --
Exercise Common Stock 8,500 $15.46 $131K
Sale Common Stock 6,674 $22.00 $147K
Holdings After Transaction: Stock Option (right to buy) — 0 shares (Direct, null); Common Stock — 84,736 shares (Direct, null)
Footnotes (1)
  1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.95 to $22.04 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1). On July 22, 2016, the reporting person was granted 8,500 stock options. The stock options vested as to 25% of the total shares on July 22, 2017, and then 1/48th of the total stock options vested monthly thereafter, with 100% of the total shares vested and exercisable on July 22, 2020, subject to the reporting person's provision of service to the issuer on each vesting date.
Shares sold 6,674 shares Common stock open-market sale on June 5, 2026
Sale price (weighted average) $22.00 per share Common stock sale range $21.95–$22.04
Options exercised 8,500 shares Stock options converted to common stock on June 5, 2026
Option exercise price $15.46 per share Stock option grant originally dated July 22, 2016
Shares owned after sale 78,062 shares Direct ownership of Trupanion common stock after transactions
Option expiration date July 22, 2026 Expiration date of exercised stock option grant
weighted average price financial
"The reported price in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Stock Option (right to buy) financial
"security_title": "Stock Option (right to buy)""
vested and exercisable financial
"with 100% of the total shares vested and exercisable on July 22, 2020"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WEINRAUCH STEVE

(Last)(First)(Middle)
6100 4TH AVENUE S
SUITE 200

(Street)
SEATTLE WASHINGTON 98108

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
TRUPANION, INC. [ TRUP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, North Am & Vet Strategy
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/05/2026M8,500A$15.4684,736D
Common Stock06/05/2026S6,674D$22(1)78,062D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$15.4606/05/2026M8,500 (2)07/22/2026Common Stock8,500$00D
Explanation of Responses:
1. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.95 to $22.04 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1).
2. On July 22, 2016, the reporting person was granted 8,500 stock options. The stock options vested as to 25% of the total shares on July 22, 2017, and then 1/48th of the total stock options vested monthly thereafter, with 100% of the total shares vested and exercisable on July 22, 2020, subject to the reporting person's provision of service to the issuer on each vesting date.
Remarks:
/s/ Lauren Welsh as attorney-in-fact for Steve Weinrauch06/09/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did TRUP executive Steve Weinrauch report in this Form 4?

Steve Weinrauch reported an exercise-and-sell transaction in Trupanion stock. He exercised 8,500 options at $15.46 per share, then sold 6,674 common shares at a weighted average price of $22.00 per share in open-market trades.

How many TRUP shares did Steve Weinrauch sell and at what price?

He sold 6,674 Trupanion common shares in open-market transactions. The weighted average sale price was $22.00 per share, with individual trades occurring between $21.95 and $22.04 per share, according to the Form 4 footnote.

How many TRUP stock options did Steve Weinrauch exercise?

He exercised 8,500 stock options for Trupanion common stock. These options had a $15.46 exercise price and were originally granted on July 22, 2016, fully vesting by July 22, 2020, before being exercised in this reported transaction.

What are Steve Weinrauch’s TRUP holdings after these transactions?

After the reported transactions, Steve Weinrauch directly owns 78,062 shares of Trupanion common stock. The exercised option grant now shows zero remaining derivative shares, indicating that particular option award has been fully used.

When were the TRUP stock options originally granted and how did they vest?

The 8,500 Trupanion stock options were granted on July 22, 2016. They vested 25% on July 22, 2017, with the remainder vesting in equal monthly installments, resulting in 100% of the options vested and exercisable by July 22, 2020.

What role does Steve Weinrauch hold at Trupanion (TRUP)?

Steve Weinrauch serves as Executive Vice President, North America & Vet Strategy at Trupanion. His Form 4 filing reflects personal transactions in Trupanion common stock and stock options in his capacity as a company officer.